Awiqli (Insulin Icodec): Uses, Benefits, Dosing & Safety Information

What Is Awiqli?

Awiqli is a once-weekly basal insulin containing insulin icodec, developed to help adults manage blood glucose levels as part of a comprehensive diabetes treatment plan. Unlike traditional basal insulins that require daily injections, Awiqli is designed for once-weekly administration, offering a more convenient option for eligible patients.

Awiqli provides long-acting blood glucose control by maintaining stable insulin levels throughout the week, making it an innovative advancement in diabetes management.

How Awiqli Works

The Product contains insulin icodec, an ultra-long-acting insulin analog engineered to release gradually over seven days.

After injection, insulin icodec:

• Helps lower blood glucose levels
• Supports normal glucose metabolism
• Reduces glucose production by the liver
• Promotes glucose uptake into muscle and fat cells
• Provides consistent basal insulin coverage throughout the week

Its extended duration allows patients to inject only once every seven days while maintaining continuous basal insulin support.

Benefits

Awiqli offers several potential advantages for appropriate patients:

• Once-weekly dosing
• Consistent basal insulin coverage
• Reduced injection frequency
• Simplified diabetes management
• Improved treatment convenience
• Predictable glucose-lowering effects
• Long-lasting insulin activity

Reducing the number of injections may help some patients better adhere to their prescribed treatment regimen.

Who May Be Prescribed Awiqli?

It  may be prescribed by healthcare professionals for adults requiring basal insulin therapy as part of their diabetes management.

Treatment decisions should always be individualized based on:

• Type of diabetes
• Current medications
• Blood glucose control
• Medical history
• Overall health status
  

  Important Safety Information

  Patients using the products should:

  • Monitor blood glucose regularly.
  • Be aware of symptoms of hypoglycemia.
  • Follow dietary and exercise recommendations.
  • Inform healthcare providers about all medications they are taking.
  • Never share insulin pens with another person.